#BEGIN_DRUGCARD DB03535

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C18H22N2O4

# Chemical_IUPAC_Name:
benzyl (2S)-2-{[(2S)-2-formylpyrrolidin-1-yl]carbonyl}pyrrolidine-1-carboxylate

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Z-Pro-Prolinal

# HET_ID:
ZPR

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C18H22N2O4/c21-12-15-8-4-10-19(15)17(22)16-9-5-11-20(16)18(23)24-13-14-6-2-1-3-7-14/h1-3,6-7,12,15-16H,4-5,8-11,13H2/t15-,16-/m0/s1

# InChI_Key:
InChIKey=ORZXYSPOAVJYRU-HOTGVXAUSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3535

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
330.3783

# Molecular_Weight_Mono:
330.157957202

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1QFS

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.25

# Predicted_LogS:
-2.3

# Predicted_Water_Solubility:
1.53e+00 g/l

# Primary_Accession_No:
DB03535

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
122623

# PubChem_Substance_ID:
46507956

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03293

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@]1(CCCN1C(=O)[C@]1([H])CCCN1C(=O)OCC1=CC=CC=C1)C=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:21 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
PREP

# Drug_Target_1_GenBank_ID_Gene:
X74496

# Drug_Target_1_GenBank_ID_Protein:
558596

# Drug_Target_1_GeneCard_ID:
PREP

# Drug_Target_1_Gene_Name:
PREP

# Drug_Target_1_Gene_Sequence:
>2133 bp
ATGCTGTCCTTCCAGTACCCCGACGTGTACCGCGACGAGACCGCCGTACAGGATTATCAT
GGTCATAAAATTTGTGACCCTTACGCCTGGCTTGAAGACCCCGACAGTGAACAGACTAAG
GCCTTTGTGGAGGCCCAGAATAAGATTACTGTGCCATTTCTTGAGCAGTGTCCCATCAGA
GGTTTATACAAAGAGAGAATGACTGAACTATATGATTATCCCAAGTATAGTTGCCACTTC
AAGAAAGGAAAACGGTATTTTTATTTTTACAATACAGGTTTGCAGAACCAGCGAGTATTA
TATGTACAGGATTCCTTAGAGGGGGAGGCCAGAGTGTTCCTGGACCCCAACATACTGTCT
GACGATGGCACAGTGGCACTCCGAGGTTATGCGTTCAGCGAAGATGGTGAATATTTTGCC
TATGGTCTGAGTGCCAGTGGCTCAGACTGGGTGACAATCAAGTTCATGAAAGTTGATGGT
GCCAAAGAGCTTCCAGATGTGCTTGAAAGAGTCAAGTTCAGCTGTATGGCCTGGACCCAT
GATGGGAAGGGAATGTTCTACAACTCATACCCTCAACAGGATGGAAAAAGTGATGGCACA
GAGACATCTACCAATCTCCACCAAAAGCTCTACTACCATGTCTTGGGAACCGATCAGTCA
GAAGATATTTTGTGTGCTGAGTTTCCTGATGAACCTAAATGGATGGGTGGAGCTGAGTTA
TCTGATGATGGCCGCTATGTCTTGTTATCAATAAGGGAAGGATGTGATCCAGTAAACCGA
CTCTGGTACTGTGACCTACAGCAGGAATCCAGTGGCATCGCGGGAATCCTGAAGTGGGTA
AAACTGATTGACAACTTTGAAGGGGAATATGACTACGTGACCAATGAGGGGACGGTGTTC
ACATTCAAGACGAATCGCCAGTCTCCCAACTATCGCGTGATCAACATTGACTTCTGGGAT
CCTGAAGAGTCTAAGTGGAAAGTACTTGTTCCTGAGCATGAGAAAGATGTCTTAGAATGG
ATAGCTTGTGTCAGGTCCAACTTCTTGGTCTTATGCTACCTCCATGACGTCAAGAACATT
CTGCAGCTCCATGACCTGACTACTGGTGCTCTCCTTAAGACCTTCCCGCTCGATGTCGGC
AGCATTGTAGGGTACAGCGGTCAGAAGAAGGACACTGAAATCTTCTATCAGTTTACTTCC
TTTTTATCTCCAGGTATCATTTATCACTGTGATCTTACCAAAGAGGAGCTGGAGCCAAGA
GTTTTCCGAGAGGTGACCGTAAAAGGAATTGATGCTTCTGATTACCAGACAGTCCAGATT
TTCTACCCTAGCAAGGATGGTACGAAGATTCCAATGTTCATTGTGCATAAAAAAGGCATA
AAATTGGATGGCTCTCATCCAGCTTTCTTATATGGCTATGGCGGCTTCAACATATCCATC
ACACCCAACTACAGTGTTTCCAGGCTTATTTTTGTGAGACACATGGGTGGTATCCTGGCA
GTGGCCAACATCAGAGGAGGTGGCGAATATGGAGAGACGTGGCATAAAGGTGGTATCTTG
GCCAACAAACAAAACTGCTTTGATGACTTTCAGTGTGCTGCTGAGTATCTGATCAAGGAA
GGTTACACATCTCCCAAGAGGCTGACTATTAATGGAGGTTCAAATGGAGGCCTCTTAGTG
GCTGCTTGTGCAAATCAGAGACCTGACCTCTTTGGTTGTGTTATTGCCCAAGTTGGAGTA
ATGGACATGCTGAAGTTTCATAAATATACCATCGGCCATGCTTGGACCACTGATTATGGG
TGCTCGGACAGCAAACAACACTTTGAATGGCTTGTCAAATACTCTCCATTGCATAATGTG
AAGTTACCAGAAGCAGATGACATCCAGTACCCGTCCATGCTGCTCCTCACTGCTGACCAT
GATGACCGCGTGGTCCCGCTTCACTCCCTGAAGTTCATTGCCACCCTTCAGTACATCGTG
GGCCGCAGCAGGAAGCAAAGCAACCCCCTGCTTATCCACGTGGACACCAAGGCGGGCCAC
GGGGCGGGGAAGCCCACAGCCAAAGTGATAGAGGAAGTCTCAGACATGTTTGCGTTCATC
GCGCGGTGCCTGAATGTCGACTGGATTCCATAA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
7959018	Vanhoof G, Goossens F, Hendriks L, De Meester I, Hendriks D, Vriend G, Van Broeckhoven C, Scharpe S: Cloning and sequence analysis of the gene encoding human lymphocyte prolyl endopeptidase. Gene. 1994 Nov 18;149(2):363-6.
8089089	Shirasawa Y, Osawa T, Hirashima A: Molecular cloning and characterization of prolyl endopeptidase from human T cells. J Biochem (Tokyo). 1994 Apr;115(4):724-9.

# Drug_Target_1_HGNC_ID:
HGNC:9358

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3873

# Drug_Target_1_Locus:
6q22

# Drug_Target_1_Molecular_Weight:
80764

# Drug_Target_1_Name:
Prolyl endopeptidase

# Drug_Target_1_Number_of_Residues:
710

# Drug_Target_1_PDB_ID:
1H2W

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00326	Peptidase_S9
PF02897	Peptidase_S9_N

# Drug_Target_1_Protein_Sequence:
>Prolyl endopeptidase
MLSFQYPDVYRDETAVQDYHGHKICDPYAWLEDPDSEQTKAFVEAQNKITVPFLEQCPIR
GLYKERMTELYDYPKYSCHFKKGKRYFYFYNTGLQNQRVLYVQDSLEGEARVFLDPNILS
DDGTVALRGYAFSEDGEYFAYGLSASGSDWVTIKFMKVDGAKELPDVLERVKFSCMAWTH
DGKGMFYNSYPQQDGKSDGTETSTNLHQKLYYHVLGTDQSEDILCAEFPDEPKWMGGAEL
SDDGRYVLLSIREGCDPVNRLWYCDLQQESSGIAGILKWVKLIDNFEGEYDYVTNEGTVF
TFKTNRQSPNYRVINIDFWDPEESKWKVLVPEHEKDVLEWIACVRSNFLVLCYLHDVKNI
LQLHDLTTGALLKTFPLDVGSIVGYSGQKKDTEIFYQFTSFLSPGIIYHCDLTKEELEPR
VFREVTVKGIDASDYQTVQIFYPSKDGTKIPMFIVHKKGIKLDGSHPAFLYGYGGFNISI
TPNYSVSRLIFVRHMGGILAVANIRGGGEYGETWHKGGILANKQNCFDDFQCAAEYLIKE
GYTSPKRLTINGGSNGGLLVAACANQRPDLFGCVIAQVGVMDMLKFHKYTIGHAWTTDYG
CSDSKQHFEWLVKYSPLHNVKLPEADDIQYPSMLLLTADHDDRVVPLHSLKFIATLQYIV
GRSRKQSNPLLIHVDTKAGHGAGKPTAKVIEEVSDMFAFIARCLNVDWIP

# Drug_Target_1_Reaction:
Hydrolysis of ---Pro! and to a lesser extent ---Ala! in oligopeptides

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Cleaves peptide bonds on the C-terminal side of prolyl residues within peptides that are up to approximately 30 amino acids long

# Drug_Target_1_SwissProt_ID:
P48147

# Drug_Target_1_SwissProt_Name:
PPCE_HUMAN

# Drug_Target_1_Synonyms:
EC 3.4.21.26
PE
Post-proline cleaving enzyme

# Drug_Target_1_Theoretical_pI:
5.58

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AF143951

# Drug_Target_2_GenBank_ID_Protein:
4973227

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
Not Available

# Drug_Target_2_Gene_Sequence:
>2073 bp
ATGTCAGGGAAAGCGCGCCTTCACTACCCCGTCACCCGCCAGGGTGAGCAGGTGGATCAC
TACTTCGGCCAGGCCGTGGCCGACCCCTATCGCTGGCTGGAGGATGATCGCAGCCCCGAG
ACCGAGGCCTGGGTCAAGGCCCAGAATGCCGTGACCCAGGACTACCTGGCACAGATCCCG
TATCGCGCTGCCATCAAGGAGAAGCTGGCCGCCTCCTGGAACTACGCCAAGGAGGGGGCG
CCGTTTCGCGAGGGGCGCTACCACTACTTCTTCAAGAACGACGGCCTGCAGAACCAGAAC
GTGCTGTGGCGCCAGAAGGAGGGCAAACCGGCGGAGGTGTTCCTAGATCCCAATACCCTC
AGCCCCGACGGCACCACGGCGCTGGATCAGCTGAGCTTCTCCCGCGATGGCCGCATCCTG
GCCTACTCGCTGTCGCTGGCGGGTAGCGACTGGCGCGAGATCCACCTGATGGACGTGGAG
AGCAAGCAGCCGCTGGAGACCCCTCTCAAGGACGTGAAATTCAGCGGCATCAGCTGGCTC
GGCAACGAGGGCTTCTTCTACTCGAGCTACGACAAGCCCGATGGCAGCGAGCTGTCGGCC
AGGACTGATCAGCACAAGGTCTATTTCCACCGGCTCGGCACGGCGCAGGAGGATGACCGG
CTGGTGTTCGGCGCCATCCCGGCCCAGCACCACCGCTACGTGGGGGCGACCGTCACCGAA
GATGACCGCTTCCTGCTCATCTCGGCGGCGAACTCCACCTCCGGCAACCGCCTCTATGTG
AAGGATCTGAGCCAGGAGAACGCGCCGCTGCTGACGGTGCAGGGGGATCTGGACGCGGAC
GTGAGCCTGGTGGACAACAAGGGCAGCACCCTATACCTGCTGACCAACCGGGACGCCCCC
AACCGCCGGCTGGTGACGGTGGATGCCGCCAACCCGGGGCCGGCCCACTGGCGCGACCTT
ATCCCCGAGCGTCACAGGGTGCTGACGGTGCACAGCGGCACGGCCTATCTGTTCGCCGAG
TACATGGTGGATGCCACCGCCCCGGTCGAGCAGTTCGACTACGAGGGCAAGCGGGTGCGC
GAGGTGGCGCTGCCCGGCCTTGGCAGCGTCAGCGGCTTCAACGGCAAGCACGACGACCCC
GCCCTCTACTTCGGCTTCGAGAACTATGCCCAGCCGCCCACTCTCTATCGGTTCGAGCCA
AAGAGCGGCGCCATCAGCCTCTATCGCGCCTCGGCGGCGCCGTTCAAGCCGGAGGATTAC
GTCTCCGAGCAGCGCTTCTACCAGAGCAAGGACGGCACCCGGGTGCCGCTCATCATCAGC
TACCGCAAGGGGCTGAAACTCGATGGCAGCAACCCGACCATCCTCTACGGCTATGGCGGT
TTTGACGTGAGCCTTACCCCGAGCTTCAGCGTATCGGTGGCCAACTGGCTGGATCTGGGG
GGCGTCTATGCGGTGGCCAACCTGCGTGGGGGCGGCGAGTACGGCCAGGCCTGGCACCTG
GCGGGCACCCAGCAGAACAAACAGAACGTGTTCGACGACTTCATCGCGGCGGCCGAGTAC
CTCAAGGCCGAGGGCTACACCCGCACCGATCGGCTGGCGATCCGCGGTGGCTCCAACGGC
GGTCTGCTGGTGGGGGCCGTGATGACCCAGCGGCCGGATCTGATGCGGGTCGCCCTGCCA
GCGGTGGGGGTGCTCGACATGCTGCGCTACCACACCTTCACCGCCGGGGCGGGCTGGGCC
TATGACTACGGCACCAGTGCCGACAGCGAGGCGATGTTCGACTACCTGAAGGGCTACTCG
CCGCTGCACAACGTCCGACCCGGGGTCAGCTACCCCTCGACTATGGTGACCACGGCGGAT
CACGACGATCGGGTGGTACCGGCTCACTCCTTCAAGTTTGCCGCCACCCTGCAGGCCGAC
AATGCGGGCCCCCATCCCCAGCTCATCCGCATCGAGACCAATGCCGGGCACGGGGCGGGT
ACGCCGGTGGCGAAGCTGATTGAGCAGAGTGCGGACATCTATGCCTTCACCCTGTACGAG
ATGGGCTACCGGGAGCTGCCGCGTCAGCCTTGA

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
Not Available

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6928

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
76635.9

# Drug_Target_2_Name:
Prolyl endopeptidase

# Drug_Target_2_Number_of_Residues:
690

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00326	Peptidase_S9
PF02897	Peptidase_S9_N

# Drug_Target_2_Protein_Sequence:
>Prolyl endopeptidase
MSGKARLHYPVTRQGEQVDHYFGQAVADPYRWLEDDRSPETEAWVKAQNAVTQDYLAQIP
YRAAIKEKLAASWNYAKEGAPFREGRYHYFFKNDGLQNQNVLWRQKEGKPAEVFLDPNTL
SPDGTTALDQLSFSRDGRILAYSLSLAGSDWREIHLMDVESKQPLETPLKDVKFSGISWL
GNEGFFYSSYDKPDGSELSARTDQHKVYFHRLGTAQEDDRLVFGAIPAQHHRYVGATVTE
DDRFLLISAANSTSGNRLYVKDLSQENAPLLTVQGDLDADVSLVDNKGSTLYLLTNRDAP
NRRLVTVDAANPGPAHWRDLIPERHRVLTVHSGTAYLFAEYMVDATAPVEQFDYEGKRVR
EVALPGLGSVSGFNGKHDDPALYFGFENYAQPPTLYRFEPKSGAISLYRASAAPFKPEDY
VSEQRFYQSKDGTRVPLIISYRKGLKLDGSNPTILYGYGGFDVSLTPSFSVSVANWLDLG
GVYAVANLRGGGEYGQAWHLAGTQQNKQNVFDDFIAAAEYLKAEGYTRTDRLAIRGGSNG
GLLVGAVMTQRPDLMRVALPAVGVLDMLRYHTFTAGAGWAYDYGTSADSEAMFDYLKGYS
PLHNVRPGVSYPSTMVTTADHDDRVVPAHSFKFAATLQADNAGPHPQLIRIETNAGHGAG
TPVAKLIEQSADIYAFTLYEMGYRELPRQP

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q9X6R4

# Drug_Target_2_SwissProt_Name:
Q9X6R4_AERPU

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
6.03

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03535
